Clinical Trial: Impact of Oral Versus Intravenous 5-FU-Based Adjuvant Regimens on Sleep Quality and Depression in Patients With Gastrointestinal Cancers

U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06996483) titled 'Impact of Oral Versus Intravenous 5-FU-Based Adjuvant Regimens on Sleep Quality and Depression in Patients With Gastrointestinal Cancers' on May 21.

Brief Summary: This prospective, single-center, observational study aims to evaluate the impact of oral versus intravenous 5-fluorouracil (5-FU)-based adjuvant chemotherapy regimens on sleep quality and depression levels in patients diagnosed with non-metastatic gastrointestinal system (GIS) cancers.

Eligible patients aged 18 years or older who are planned to receive adjuvant chemotherapy at the medical oncology outpatient clinic will be assessed using the Pittsburgh Sleep Quality Index...